Advisory Board and Editors Molecular Biology
Duangjai Tungmunnithum
Assoc. Prof. Dr. Duangjai Tungmunnithum completed her Ph.D. at Chulalongkorn University in 2016, and won the DPST Postdoctoral Fellowship to conduct her Postdoctoral research in Japan at the National Museum of Nature and Science focusing on medicinal plant and phytochemistry in the same year. After completing her research in Japan, she obtained a lecturer position at the Faculty of Pharmacy, Mahidol University, Thailand.
Her expertise is in biochemistry, innovative green extraction methods, biological activity both antioxidant and anti-aging from plant extracts and pure phytochemical compounds for cosmetic and pharmaceutical applications both in vitro, in vivo and in cellulo models.
According to her research profiles, she has received a large number of outstanding research both national and international levels e.g. the Junior Research Fellowship from French Government, Franco-Thai Mobility Programme 2020-2021 and LE STUDIUM Research Fellowship.
Konstantin K. Turoverov
Professor of Molecular Biology, Head of the Laboratory of Structural Dynamics, Stability and Folding of Proteins of the Institute of Cytology, Russian Academy of Science.
Rohit Upadhyay
Dr. Rohit Upadhyay is a Research Scientist in the School of Medicine at Tulane University.
He has skills and expertise in the following areas; Cancer Genetics, Cell and Molecular biology, Kidney Injury, Pharmacology, and Molecular mechanisms of complex diseases.
Vladimir N Uversky
Professor at the Department of Molecular Medicine of University of South Florida, College of Medicine, and Visiting Professor at Moscow Institute of Physics and Technology.
I received my B.S. and M.S. degrees in Physics from Leningrad State University in Russia in 1986, then, completed Ph.D. and Doctor of Sciences (D.Sc.) degrees in Physics and Mathematics (field of study - Biophysics) at the Moscow Institute of Physics and Technology (1991) and the Institute Experimental and Theoretical Biophysics of the Russian Academy of Sciences (1998), respectively. I spent early career working on protein folding at Institute of Protein Research and the Institute for Biological Instrumentation (Russia). In 1998, I moved to the University of California Santa Cruz to study protein folding, misfolding, protein conformation diseases, and protein intrinsic disorder phenomenon. In 2004, I was invited to join the Indiana University School of Medicine to primary work on the intrinsically disordered proteins. Since 2010, I am with USF, where I continue to study intrinsically disordered proteins and analyze protein folding and misfolding processes.
I have authored over 950 scientific publications. I am an editor of several scientific journals and edited a number of books and book series on protein structure, function, folding, and misfolding. Since 2014, I am included by the Thomson Reuters to the Clarivate list of Highly Cited Researchers™.
Ece Uzun
Dr. Ece Uzun is the Director of Clinical Bioinformatics at Lifespan Academic Medical Center and Assistant Professor at the Department of Pathology and Laboratory Medicine at Brown University Alpert Medical School. In her clinical work, Dr. Uzun focuses on building bioinformatics analysis pipelines, developing algorithms, tools and databases to aid in clinical variant detection and annotation. In addition to her clinical work, Dr. Uzun's research group develops novel algorithms to analyze big data and gene networks with a focus on complex disorders such as cancer and neurodevelopmental disorders.
Carine Van Lint
After performing her PhD thesis at the National Institutes of Health (NIH, Bethesda, USA) from 1991 to 1994 and a postdoctoral fellowship in New York from 1994 to 1997, Carine Van Lint joined the Faculty of Sciences of the "Université Libre de Bruxelles" as the head of the Laboratory of Molecular Virology. As a biochemist, Carine Van Lint has developed for the last 25 years a specific interest for pathogenic retroviruses. Her laboratory is mainly studying the role played by epigenetic modifications (such as histone acetylation, histone methylation and DNA methylation) and by non-epigenetic regulatory elements in transcriptional latency and reactivation of HIV-1 (Human Immunodeficiency Virus type 1 - the ethiologic agent of the acquired immunodeficiency syndrome (AIDS)), BLV (Bovine Leukemia Virus - the etiologic agent of a chronic lymphoproliferative disease termed enzootic bovine leucosis) and HTLV-1 (Human T-cell leukemia virus 1 - the etiologic agent of an aggressive lymphoproliferative disease (Adult T-cell Leukemia/Lymphoma) and a neurological degenerative syndrome (tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM)).
Laurence Vandel
University of Clermont-Auvergne
Director of research at CNRS
Research fields include, epigenetic enzymes, transcription regulation, cell differentiation and cancer.
Ana Tereza Ribeiro Vasconcelos
Ana Tereza Vasconcelos is Senior Researcher Scientist at the National Laboratory for Scientific Computing and coordinator of the Bioinformatics Laboratory and the Computational Genomics Unit Darcy Fontoura de Almeida at National Laboratory of Scientific Computation (LNCC). Her team has experience in the area of Bioinformatics and Computational Biology. Using High Performance Computing and AI working on the following topics: Genomics, Development of software applications in Bioinformatics and computational tools applied assembly, annotation and comparison of genomes, metagenomics, exomes and transcriptomics applied to many different model organisms. Since 2020 he has worked in the generation and analysis of SARS-CoV-2 genomes, mainly in the identification of new lineages.
Yegor S Vassetzky
Yegor Vassetzky graduated from the Moscow State University. After a PhD thesis in molecular biology at the Engelhardt Institute of Molecular Biology in Moscow, he worked as a postdoctoral fellow in laboratories of Klaus Scherrer (Paris), Susan Gasser (Lausanne) and Marcel Méchali (Montpellier). Since 2002 he heads the laboratory of Nuclear Organization and Pathologies at Gustave Roussy Institute (Villejuif, France). His main research interests concern epigenetic regulation in cancer and neuromuscular diseases. Yegor Vassetzky is Associate Editor for Biopolymers & Cell, and member of the Editorial Board of PeerJ and Oncotarget.
David Vauzour
Dr David VAUZOUR received his PhD from the University of Montpellier (France) in 2004. His research, based at the University of Reading (2005-2011), and at the Norwich Medical School, University of East Anglia, UK (2011- present), has focused on investigating the molecular mechanisms that underlie the accumulating body of epidemiological, and medical evidence, on a positive correlation between the consumption of diets rich in fruits and vegetables and a decreased risk of (neuro)degenerative disorders. In this context, his initial work provided considerable insights into the potential for natural products to promote human vascular function, decrease (neuro)inflammation, enhance memory, learning and neuro-cognitive performances and to slow the progression of Alzheimer’s and Parkinson’s diseases. His recent interests concern how phytochemicals modulate ApoE genotype-induced cardiovascular risk and neurodegenerative disorders and their underlying mechanisms. Dr Vauzour sits on the board committee of “Groupe Polyphenols” and is the Co-Chair of the ILSI Europe “Nutrition and Mental Performance Task Force“.
Natascia Ventura
Natascia Ventura received her MD and PhD degrees at the University of Rome and her post-doctoral training at the University of Colorado at Boulder. Since 2012 she leads the Mitochondrial-associated aging and diseases group and her research mainly uses C. elegans as a powerful genetic tractable organism to unravel mechanistic aspects of mitochondrial-stress control of longevity and to develop models for human mitochondrial-associated diseases.
Alexis Verger
Senior Molecular Biologist (CR1 CNRS) at the Interdisciplinary Research Institute (IRI) - Lille 1 University - France.
My lab studies how human genes can be turned on and off by transcription factors. We investigate the fundamental mechanisms underlying specific gene control in the context of diseases, such as cancer.